Cargando…
Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico
BACKGROUND: The first case of SARS-CoV-2 in Mexico was reported in February 2020, since then, high rates of mortality due to COVID-19 have been found. Cytokine storm is linked to the severity and decreasing the survival among infected patients by COVID-19. The serum levels of Interleukin 6 (IL-6) ha...
Autores principales: | Avila-Nava, Azalia, Cortes-Telles, Arturo, Torres-Erazo, Darwin, López-Romero, Stephanie, Chim Aké, Rodolfo, Gutiérrez Solis, Ana Ligia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052471/ https://www.ncbi.nlm.nih.gov/pubmed/33896708 http://dx.doi.org/10.1016/j.cyto.2021.155543 |
Ejemplares similares
-
Cystatin C is a marker for acute kidney injury, but not for mortality among COVID-19 patients in Mexico
por: Ramos-Santos, Karime, et al.
Publicado: (2022) -
Dynamic inflammatory response among routine laboratory biomarkers and their predictive ability for mortality in patients with severe COVID-19
por: Cortes-Telles, Arturo, et al.
Publicado: (2022) -
Oxidative Stress Biomarkers and Their Association with Mortality among Patients Infected with SARS-CoV-2 in Mexico
por: Avila-Nava, Azalia, et al.
Publicado: (2022) -
Relationship between lipid accumulation product and oxidative biomarkers by gender in adults from Yucatan, Mexico
por: Lugo, Roberto, et al.
Publicado: (2022) -
Mobile Apps for the Management of Comorbid Overweight/Obesity and Depression/Anxiety: A Systematic Review
por: Gómez-de-Regil, Lizzette, et al.
Publicado: (2020)